Adventris Pharmaceuticals (YC W23) — Adventris makes cancer vaccines
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes.
Adventris Pharmaceuticals is a Y Combinator company in the Winter 2023 batch. Its directory entry describes it as: Adventris makes cancer vaccines. The founders listed are Jen Herbach (Founder), William Collis (Founder), Mark Yarchoan (Founder) (Y Combinator directory entry, January 31, 2023).
Get an email when Adventris Pharmaceuticals changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Adventris Pharmaceuticals?
Get the full cited report on Adventris Pharmaceuticals
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.
If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com
Jen Herbach
Founder
William Collis
Founder
Mark Yarchoan
Founder
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 60 companies held here in Healthcare › Drug Discovery and Delivery.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Adventris Pharmaceuticals?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Adventris Pharmaceuticals: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Adventris Pharmaceuticals covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Adventris Pharmaceuticals: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
